Texas Instruments (TI) has launched the F28E12x series of ultra-low-cost C2000 real-time MCUs for motor control based on a ...
Researchers from Drexel University’s School of Education will join peers from Ursinus College and the 21st Century ...
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback